LOKELMA 10 g, powder for oral suspension 3 sachets
Active ingredients: CYCLOSILICATE DE ZIRCONIUM SODIQUE
Commercialized according to BDPMDispensing in France: Prescription only
Powder for oral suspension3 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOKELMA 10 g, poudre pour suspension buvable
- Pharmaceutical form
- poudre pour suspension buvable
- Route of administration
- orale
- Presentation description
- 3 sachet(s) polytéréphtalate (PET) PEBDL : polyéthylène à basse densité linéaire aluminium
- Marketing authorisation holder
- ASTRAZENECA AB
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Feb 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64247885CIP73014809CIP133400930148099Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CYCLOSILICATE DE ZIRCONIUM SODIQUEpoudre | 10 g · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.